Order Article Reprints

Furtner J, Nenning K-H, Roetzer T, Gesperger J, Seebrecht L, Weber M, Grams A, Leber SL, Marhold F, Sherif C, et al. Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. Cancers. 2021; 13(3):566. https://doi.org/10.3390/cancers13030566

Furtner, Julia, Karl-Heinz Nenning, Thomas Roetzer, Johanna Gesperger, Lukas Seebrecht, Michael Weber, Astrid Grams, Stefan L. Leber, Franz Marhold, Camillo Sherif, and et al. 2021. "Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma" Cancers 13, no. 3: 566. https://doi.org/10.3390/cancers13030566

Furtner, J., Nenning, K.-H., Roetzer, T., Gesperger, J., Seebrecht, L., Weber, M., Grams, A., Leber, S. L., Marhold, F., Sherif, C., Trenkler, J., Kiesel, B., Widhalm, G., Asenbaum, U., Woitek, R., Berghoff, A. S., Prayer, D., Langs, G., Preusser, M., & Wöhrer, A. (2021). Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma. Cancers, 13(3), 566. https://doi.org/10.3390/cancers13030566